Your browser doesn't support javascript.
loading
Antinuclear antibodies in healthy people and non-rheumatic diseases - diagnostic and clinical implications.
Grygiel-Górniak, Bogna; Rogacka, Natalia; Puszczewicz, Mariusz.
Afiliación
  • Grygiel-Górniak B; Department of Rheumatology and Internal Medicine, Poznan University of Medical Sciences, Poland.
  • Rogacka N; Department of Rheumatology and Internal Medicine, Poznan University of Medical Sciences, Poland.
  • Puszczewicz M; Department of Rheumatology and Internal Medicine, Poznan University of Medical Sciences, Poland.
Reumatologia ; 56(4): 243-248, 2018.
Article en En | MEDLINE | ID: mdl-30237629
ABSTRACT
The presence of antinuclear antibodies (ANA) is mainly associated with connective tissue diseases (CTD). In addition, their presence is found in healthy people. These antibodies are more common in women and the elderly. Some drugs and xenobiotics are also important for the development of autoimmunity and ANA synthesis. Moreover, the deficiency of vitamin D in the body of patients correlates with occurrence of these antibodies. Unlike the healthy group, a positive ANA count was observed in patients with atopic dermatitis (AD) and in people with immune disorders. Antinuclear antibodies in low counts are also found in the course of chronic bacterial or viral infection and in patients with hematological malignancies. Also the possibility of false positive results, which may be caused by the choice of method used to determine antibodies, should be borne in mind. Taking into account all these factors, it is concluded that the ANA result itself has no diagnostic value.
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: En Año: 2018 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: En Año: 2018 Tipo del documento: Article